Reactions Weekly

, Volume 1688, Issue 1, pp 87–87 | Cite as

Dexamethasone/lenalidomide/proteasome inhibitor interaction

Ventricular tachycardia and myocardial fibrosis: case report
Case report


  1. Fradley MG, et al. Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British Journal of Haematology 180: 271-275, No. 2, Jan 2018. Available from: URL: - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations